The results showed that tumor tissues from EGFR TKI-resistant patients had significantly increased GLI1, SMO, BCL2, and SNAIL protein levels compared with those from TKI-sensitive cases (Fig. 1A), suggesting that these proteins are possibly related to TKI resistance in NSCLC. The gene discussed is BCL2; the disease is non-small cell lung carcinoma.